Lilly BioVentures

Lilly Ventures is the corporate venture capital arm of Eli Lilly and Company, dedicated to investing in early-stage life science companies with breakthrough potential. Founded in 2001 and headquartered in Indianapolis, the firm focuses on strategic investments that align with Lilly's core therapeutic areas, including oncology, immunology, neuroscience, and cardiometabolic diseases. Lilly Ventures provides not only capital but also scientific expertise and access to Lilly's global network to accelerate the development of innovative therapies and platforms. The firm manages a diverse portfolio of direct investments and also participates in the broader life science fund ecosystem. Its mission is to identify and support the "tip of the spear" in emerging science to deliver the next generation of life-changing medicines.